Ildiko M. Buck

905 total citations
17 papers, 440 citations indexed

About

Ildiko M. Buck is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Ildiko M. Buck has authored 17 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 4 papers in Organic Chemistry. Recurrent topics in Ildiko M. Buck's work include Neuropeptides and Animal Physiology (6 papers), Receptor Mechanisms and Signaling (4 papers) and Chemical Synthesis and Analysis (3 papers). Ildiko M. Buck is often cited by papers focused on Neuropeptides and Animal Physiology (6 papers), Receptor Mechanisms and Signaling (4 papers) and Chemical Synthesis and Analysis (3 papers). Ildiko M. Buck collaborates with scholars based in United Kingdom, United States and France. Ildiko M. Buck's co-authors include S. Barret Kalindjian, Michael J. Pether, Iain M. McDonald, Caroline M. R. Low, Matthew J. Tozer, Nigel P. Shankley, Ian D. Linney, Elaine A. Harper, Colin B. Reese and Pamela A. Williams and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Tetrahedron.

In The Last Decade

Ildiko M. Buck

17 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ildiko M. Buck United Kingdom 13 275 164 73 64 48 17 440
Catherine Prouty United States 14 330 1.2× 181 1.1× 47 0.6× 55 0.9× 54 1.1× 17 483
Hitoshi Sakashita Japan 10 220 0.8× 80 0.5× 45 0.6× 75 1.2× 50 1.0× 19 409
Michael J. Pether United States 12 194 0.7× 131 0.8× 92 1.3× 61 1.0× 35 0.7× 16 331
Nalin L. Subasinghe United States 12 198 0.7× 238 1.5× 48 0.7× 30 0.5× 49 1.0× 17 419
Carolyn A. Weigelt United States 14 255 0.9× 147 0.9× 100 1.4× 53 0.8× 169 3.5× 25 520
Jesús Vázquez Spain 10 265 1.0× 100 0.6× 42 0.6× 23 0.4× 65 1.4× 12 368
John M. Pritchard United Kingdom 11 191 0.7× 81 0.5× 44 0.6× 31 0.5× 38 0.8× 17 367
Naoko Katayama Japan 13 248 0.9× 125 0.8× 65 0.9× 135 2.1× 28 0.6× 19 511
Giampiero Pagani Zecchini Italy 16 507 1.8× 294 1.8× 89 1.2× 93 1.5× 59 1.2× 57 682
Ronald Wolin United States 13 213 0.8× 279 1.7× 36 0.5× 55 0.9× 39 0.8× 23 503

Countries citing papers authored by Ildiko M. Buck

Since Specialization
Citations

This map shows the geographic impact of Ildiko M. Buck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ildiko M. Buck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ildiko M. Buck more than expected).

Fields of papers citing papers by Ildiko M. Buck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ildiko M. Buck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ildiko M. Buck. The network helps show where Ildiko M. Buck may publish in the future.

Co-authorship network of co-authors of Ildiko M. Buck

This figure shows the co-authorship network connecting the top 25 collaborators of Ildiko M. Buck. A scholar is included among the top collaborators of Ildiko M. Buck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ildiko M. Buck. Ildiko M. Buck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Tamanini, Emiliano, Ildiko M. Buck, Gianni Chessari, et al.. (2017). Discovery of a Potent Nonpeptidomimetic, Small-Molecule Antagonist of Cellular Inhibitor of Apoptosis Protein 1 (cIAP1) and X-Linked Inhibitor of Apoptosis Protein (XIAP). Journal of Medicinal Chemistry. 60(11). 4611–4625. 57 indexed citations
2.
Chessari, Gianni, Ildiko M. Buck, James E. H. Day, et al.. (2015). Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Discovery of a Non-Alanine Lead Series with Dual Activity Against cIAP1 and XIAP. Journal of Medicinal Chemistry. 58(16). 6574–6588. 67 indexed citations
3.
McDonald, Iain M., Carol Austin, Ildiko M. Buck, et al.. (2006). Novel, Achiral 1,3,4-Benzotriazepine Analogues of 1,4-Benzodiazepine-Based CCK2 Antagonists That Display High Selectivity over CCK1 Receptors. Journal of Medicinal Chemistry. 49(7). 2253–2261. 32 indexed citations
4.
Ormerod, Dominic, et al.. (2005). Development of a Scalable Synthesis of Gastrazole (JB95008):  A Potent CCK2 Receptor Antagonist. Organic Process Research & Development. 9(4). 499–507. 12 indexed citations
5.
Low, Caroline M. R., Ildiko M. Buck, S. Barret Kalindjian, et al.. (2005). Scaffold Hopping with Molecular Field Points:  Identification of a Cholecystokinin-2 (CCK2) Receptor Pharmacophore and Its Use in the Design of a Prototypical Series of Pyrrole- and Imidazole-Based CCK2 Antagonists. Journal of Medicinal Chemistry. 48(22). 6790–6802. 35 indexed citations
6.
Tozer, Matthew J., et al.. (2002). ω-(Imidazol-4-yl)alkane-1-sulfonamides: a new series of potent histamine H3 receptor antagonists. Bioorganic & Medicinal Chemistry. 10(2). 425–432. 9 indexed citations
7.
Gibson, Susan E., et al.. (2002). CCK2 receptor antagonists containing the conformationally constrained phenylalanine derivatives, including the new amino acid Xic. European Journal of Medicinal Chemistry. 37(5). 379–389. 22 indexed citations
8.
Linney, Ian D., Ildiko M. Buck, Elaine A. Harper, et al.. (2000). Design, Synthesis, and Structure−Activity Relationships of Novel Non-Imidazole Histamine H3 Receptor Antagonists. Journal of Medicinal Chemistry. 43(12). 2362–2370. 59 indexed citations
9.
Low, Caroline M. R., J.W. Black, Howard B. Broughton, et al.. (2000). Development of Peptide 3D Structure Mimetics:  Rational Design of Novel Peptoid Cholecystokinin Receptor Antagonists. Journal of Medicinal Chemistry. 43(19). 3505–3517. 13 indexed citations
10.
Tozer, Matthew J., et al.. (1999). 4-Chlorobenzyl sulfonamide and sulfamide derivatives of histamine homologues: The design of potent histamine H3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 9(21). 3103–3108. 19 indexed citations
11.
Kalindjian, S. Barret, Ildiko M. Buck, Martin L. Hudson, et al.. (1996). Non-Peptide Cholecystokinin-B/Gastrin Receptor Antagonists Based on Bicyclic, Heteroaromatic Skeletons. Journal of Medicinal Chemistry. 39(9). 1806–1815. 40 indexed citations
12.
Kalindjian, S. Barret, Ildiko M. Buck, Martin L. Hudson, et al.. (1995). Improving the Affinity and Selectivity of a Nonpeptide Series of Cholecystokinin-B/Gastrin Receptor Antagonists Based on the Dibenzobicyclo[2.2.2]octane Skeleton. Journal of Medicinal Chemistry. 38(21). 4294–4302. 19 indexed citations
13.
Kalindjian, S. Barret, Michael J. Bodkin, Ildiko M. Buck, et al.. (1994). A New Class of Non-peptidic Cholecystokinin-B/Gastrin Receptor Antagonists Based on Dibenzobicyclo[2.2.2]octane. Journal of Medicinal Chemistry. 37(22). 3671–3673. 17 indexed citations
14.
Buck, Ildiko M., et al.. (1994). Conversion of guanosine into acyclovir and its 6-deoxy derivative. Tetrahedron. 50(30). 9195–9206. 9 indexed citations
15.
Grierson, David S., et al.. (1992). Synthesis of 20-deethylsilicine from a second-generation 2-cyano-.DELTA.3-piperidine synthon. The Journal of Organic Chemistry. 57(24). 6414–6421. 20 indexed citations
16.
Buck, Ildiko M., et al.. (1991). “Tandem” reactivity of 2-cyano-Δ3-piperideines: a new approach to the synthesis of ervatamine type indole alkaloids.. Tetrahedron Letters. 32(39). 5413–5416. 2 indexed citations
17.
Buck, Ildiko M. & Colin B. Reese. (1990). An unambiguous synthesis of adenylosuccinic acid and its constituent nucleoside. Journal of the Chemical Society Perkin Transactions 1. 2937–2937. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catherine Prouty Breakdown of academic impact, for papers by Hitoshi Sakashita Breakdown of academic impact, for papers by Michael J. Pether Breakdown of academic impact, for papers by Nalin L. Subasinghe Breakdown of academic impact, for papers by Carolyn A. Weigelt Breakdown of academic impact, for papers by Jesús Vázquez Breakdown of academic impact, for papers by John M. Pritchard Breakdown of academic impact, for papers by Naoko Katayama Breakdown of academic impact, for papers by Giampiero Pagani Zecchini Breakdown of academic impact, for papers by Ronald Wolin
Rankless by CCL
2026